Mature human hepatocytes are not suitable for large-scale in vitro applications that rely on hepatocyte function, due to their limited availability and insufficient proliferation capacity in vitro. In contrast, human fetal liver cells (HFLC) can be easily expanded in vitro. In this study we evaluated the hepatic function of HFLCs under proliferative conditions, to determine whether HFLCs can replace mature hepatocytes for in vitro applications. HFLCs were isolated from fetal livers of 16 weeks gestation. Hepatic functions of HFLCs were determined in primary culture and after expansion in vitro. Clonal derivatives were selected and tested for hepatic functionality. Results were compared to primary mature human hepatocytes in vitro. No differences were observed between primary HFLCs and mature human hepatocytes in albumin production and mRNA levels of various liver-specific genes. Ureagenesis was 4.4-fold lower and ammonia elimination was absent in HFLCs. Expanding HFLCs decreased hepatic functions and increased cell stretching. In contrast, clonal derivatives had stable functionality and morphology and responded to differentiation stimuli. Although their hepatic functions were higher than in passaged HFLCs, functionality was at least 20 times lower compared to mature human hepatocytes. HFLCs cannot replace mature human hepatocytes in in vitro applications requiring extensive in vitro expansion, because this is associated with decreased hepatic functionality. Selecting functional subpopulations can, at least partly, prevent this. In addition, defining conditions that support hepatic differentiation is necessary to obtain HFLC cultures suitable for in vitro hepatic applications.
INTRODUCTION
p450 activity. In addition, in the case of bioartificial liver applications, the use of cells originating from tumors raises questions about the risk of transmigration of For in vitro applications relying on hepatocytes, like bioartificial liver systems and pharmacological or toxi-tumor cells into the patient (15). Alternatively, the possibility of using human fetal cological assays, mature human hepatocytes are the preferred cell source because of their excellent function. liver cells (HFLC) for in vitro hepatocyte applications has been investigated because these cells are reported to However, due to their limited availability and insufficient proliferation capacity in vitro, mature human hepa-possess a high proliferation capacity in vitro (13). However, their functionality is less well described, which tocytes are not suitable for large-scale applications. Therefore, much effort has been put into the development may be due to variations in the fetal age and the culture conditions applied (11, 13, 21, 27) . In addition, the func-of an alternative cell source that combines well-differentiated hepatic function with the possibility to expand cell tionality of HFLCs is rarely compared to that of primary mature human hepatocytes that are maintained under the mass in vitro. In this respect tumor-derived cell lines, originating from hepatoma or hepatoblastoma (15, 22) , same conditions. This comparison is crucial for the evaluation of alternative cell sources, because at this mo-and in vitro immortalized cell lines have been investigated (8, 18, 32) . In general, these cell lines exhibit suffi-ment the primary mature hepatocytes are considered to be the functional standard for in vitro applications. cient proliferation capacity, but low hepatic functionality, like urea production from ammonia and cytochrome
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in vitro is strongly dependent on the proliferation stimu-measurement of the diameter of the skull and ranged from 14 to 18 weeks. The use of this tissue was ap-lus provided to the cells. When HFLCs are kept under conditions that only mildly stimulate proliferation, he-proved by the Medical Ethical Committee of the Academic Medical Center and was contingent on informed patic phenotype can be maintained for several weeks (11) . HFLCs maintained in primary culture for 10-12 consent. We isolated HFLCs on three independent occasions; in each case four fetal livers were pooled. HFLCs months have been reported to form organoids, containing epithelial structures and connective tissue (11). When were isolated and cultured by methods adapted from the protocol described by Malhi et al. (13) . Fetal livers were fetal liver cell cultures are exposed to proliferation-stimulating conditions, their hepatic functionality might de-digested with 0.03% collagenase P (Roche) in Hank's balanced salt solution (BioWhittaker) for 30 min at crease. Downregulation of retinoblastoma protein, which leads to cell cycle progression, rapidly decreased hepa-37°C. Dissociated cells were pelleted at 160 × g for 5 min at 4°C and washed two times with DMEM culture tocyte markers, like albumin and α-fetoprotein (AFP) secretion in rat fetal liver cells (5). Expansion of fetal medium (Dulbecco's modified Eagle's medium, Bio Whittaker) containing 10% heat-inactivated fetal bovine liver cells by subculturing may further enhance the dedifferentiation process (13). Serial passaging decreased serum (HI-FBS, BioWhittaker), 2 mM L-glutamine (Bio Whittaker), 1 µM dexamethason (Sigma), 10 µg/ml in-the number of albumin expressing HFLCs (11) and changed cell morphology from hepatocyte-like shape to sulin, 5.5 µg/ml transferrin, 6.7 ng/ml selenium-X (ITS mix, Life Technology), 100 U/ml penicillin, 100 µg/ml flattened and spindle-like (13). This may be explained by a selective advantage of cells optimally adapted to streptomycin (penicillin/streptomycin mix, BioWhittaker). HFLCs were seeded in DMEM culture medium at a den-culture conditions and displaying the highest proliferation capacity during culture. An indication in this direc-sity of approximately 3 × 10 5 cells/cm 2 in Primaria sixwell plates (BD Falcon). To obtain clonal derivatives, a tion might be given by Lazaro et al., who reported the presence of large and small hepatocytic cells in HFLC limiting dilution assay was performed after the second passage of the HFLCs. To support the cells during this cultures and observed that smaller cells became more evident during prolonged culture (11). A second possi-single-cell state, cells were seeded in Primaria 96-well plates and DMEM culture medium was enriched with bility is that HFLCs undergo a transition during in vitro culturing, analogous to the epithelial-mesenchymal 50% culture medium conditioned for 24 h by HFLCs that were passaged twice. This regime was terminated transition (EMT) described for fetal and neonatal rat hepatocytes in culture (17, 30) . Downregulation of hepato-and DMEM culture medium, as described above, was used when cells reached confluence and were transferred cyte nuclear factor (HNF) 1α and HNF4 characterizes the dedifferentiation process occurring during EMT from the 96-well plates. Clonal derivatives were selected based on morphology. Cells with a fibroblast-like mor- (30) . Although the underlying mechanism of the changes in proliferative HFLC cultures are unclear, the phology, defined as spindle-shaped cells, were excluded; cells with an epithelial morphology, defined as cubic instability of the HFLC cultures implicates that selection is necessary to obtain a homogenous cell population or cells, were further analyzed. Near-confluent cultures were split at 1:4 ratios. Cells that HFLCs cannot be extensively expanded in vitro, pending an improvement of differentiating culture con-were detached by 5-min incubation with 0.25% trypsin/ 0.03% EDTA (BioWhittaker). The number of popula-ditions.
In the present study we examined the possibility of tion doublings (PD) was calculated as PD = log(N f /N i )/ log 2 , in which N f is the final number of cells harvested using HFLCs under proliferative conditions for in vitro applications as an alternative for mature human hepato-and N i is the number of initially seeded cells. No corrections were made for cells that did not reattach after pas-cytes. The hepatic function of HFLCs was determined before and during expansion in vitro and compared to saging, because their proportion was negligible. PD time (T PD ) was calculated over the period in which PD num-the function of mature human hepatocytes under the same culture conditions. Furthermore, we investigated ber progressed linear with culture time. Mature primary human hepatocytes were isolated whether stable cultures could be obtained by selecting clonal derivatives and whether hepatic function could be from seven 2-10-g nontumor liver tissue from patients undergoing partial hepatectomy because of secondary stabilized or induced.
carcinoma. The procedure was approved by the Medical
MATERIALS AND METHODS
Ethical Committee of the Academic Medical Center and Cell Isolation and Culture was contingent on informed consent. Hepatocyte isolation method was adapted from the protocol described by Human fetal livers were obtained from elective abortions. Gestational age was determined by ultrasonic Seglen (26) . Briefly, liver tissue was flushed through the veins with ice-cold Ringers glucose solution (NPBI) PCNA Staining containing 10 U/ml heparin (Leo Pharma), until it was Freshly isolated HFLCs were seeded into eight-well free of blood. Then 100 ml of calcium-free buffer [137 culture slides (BD Falcon) in DMEM medium as de-mM NaCl (Merck), 2.7 mM KCl (Merck), 0.5 mM EGTA scribed. Two or 6 days after seeding, the cells were (Boehringer Mannheim), 10 mM HEPES (Roche), 10 washed twice with PBS and fixated by a 10-min incuba-mM glucose (Merck), 0.7 mM Na 2 HPO 4 (Merck), 100 tion with ice-cold methanol/aceton/water mixture (2:2: IU/ml penicillin-G (Yamanouchi), 40 mg/L gentamycin 1). Slides were stored in 70% ethanol at 4°C. To detect (BioWhittaker), 100 mg/L vancomycin (Eli Lilly), 2 mg/ proliferating cell nuclear antigen (PCNA), slides were L flucanozol (Diflucan, Pfizer Inc.), pH 7.5] at 37°C washed three times 5 min in PBS, then incubated for 30 was perfused through the liver tissue for 10 min. To min with Teng-T (10 mM TRIS-HCl, 5 mM EDTA, 150 dissociate the cells, the tissue was then perfused with mM NaCl, 0.25% gelatin, 0.05% Tween-20, pH 8.0) and 100 ml digestion buffer [137 mM NaCl, 2.7 mM KCl, for 2 h with Teng-T containing 200 ng/ml anti-PCNA 5 mM CaCl 2 (Merck), 10 mM HEPES, 10 mM glucose, antibody (Santa Cruz, sc-56). Slides were washed three 0.7 mM Na 2 HPO 4 , 0.4 g/L collagenase P (Roche), 100 times 5 min in PBS, incubated for 1 h in PBS containing IU/ml penicillin-G, 40 mg/L gentamycin, 100 mg/L van-2 µg/ml goat-anti-mouse IgG antibody-Alexa594 conjucomycin, 2 mg/L flucanozol, pH 7.5] at 37°C for 15 gated (Molecular Probes, A11005), washed three times min. Digested liver was sliced into small pieces and fil-5 min in PBS and mounted in Vectashield mounting metrated through surgical gauze. Dissociated liver cells dium containing diamidinophenylindoldiacetat (DAPI, were pelleted at 50 × g for 3 min at 4°C and washed Vector Laboratories). Photographs were made with a twice with WE culture medium [William's E medium Leica DM RA2 microscope using a Leica DC350F digiwith 4% HI-FBS, 2 mM L-glutamine, 1 µM dexamethatal camera and FW4000 software. Instrument settings son, 20 mU/ml insulin (Novo Nordisk), 2 mM ornithine were kept constant for all photographs. (Sigma-Aldrich), 100 U/ml penicillin, 100 µg/ml strep-RT-PCR tomycin]. The viability and yield was determined by trypan blue exclusion test. Hepatocytes were seeded in WE RNA was isolated from HFLCs and clonal derivatives that were cultured for 72 h in WE culture medium. culture medium at a density of 10 5 cells/cm 2 in Primaria six-well plates. All cells were cultured at 37°C in a hu-As a reference for hepatocyte-specific genes, RNA was isolated from two 0.2-0.5 g snap frozen liver samples. midified 5% CO 2 atmosphere.
RNA was isolated using TRIzol (Boehringer Mann-Hepatic Function Tests heim). As a reference for cholangiocyte-specific genes, RNA from two cholangiocyte cell lines, Mz-ChA-1 and Hepatic function was tested two days after seeding mature hepatocytes and HFLCs or at confluence of pas-Sk-ChA-1, was kindly delivered by M. Lie-a-Ling and C. T. Bakker (Academic Medical Center, Amsterdam). saged HFLCs and clonal derivatives in six-well plates. Culture medium was replaced by 2.5 ml of test medium First-strand cDNA was generated from 500 ng of total RNA using 20 pmol of gene-specific RT primer for the (WE culture medium with 0.5 mM NH 4 Cl) after washing the cells twice with phosphate-buffered saline (PBS, mRNA of albumin, α-1-antitrypsin (AAT), transferrin, AFP, π class glutathione-S-transferase (GSTπ), hepato-NBPI International). Medium samples were taken after 0 and 8 h (mature hepatocytes) or 72 h (HFLCs and cyte nuclear factor 4 (HNF4), HNF1α, cytochrome P450-3A4 (Cyp3A4), Cyp3A7, cytokeratin 7 (CK7), and clonal derivatives) of incubation. The cells were then washed twice with PBS and stored at −20°C for protein CK19 in combination with 5 pmol of RT primer for 18S ribosomal RNA and 134 units Superscript III (Invitrogen). determination. All experiments were performed in triplicate.
Real-time reverse transcription PCR (RT-PCR) using SYBR green I (Roche) was performed as described pre-In the differentiation experiments, confluent cultures of HFLCs and clonal derivatives were incubated for 4 viously (6). The sequences of the RT and PCR primers and PCR conditions are given in Table 1 . days in WE culture medium containing 1% dimethyl sulfoxide (DMSO, Sigma), 10 mM nicotinamide (NA, Starting levels of mRNA were calculated by analyzing linear regression on the log (fluorescence) per cycle Sigma), 10 ng/ml oncostatin M (OSM, Research Diagnostics, Inc.), 5 mM sodiumbutyrate (Sigma), 1 µM all-number data using LinRegPCR software (19) . Starting levels of mRNA calculated for albumin, AAT, transfertrans retinoic acid (RA, Sigma), 10 ng/ml hepatocyte growth factor (HGF, BD Biosciences), or 10 ng/ml fi-rin, AFP, GSTπ, HNF4, HNF1α, Cyp3A4, Cyp3A7, CK7, and CK19 were normalized for the starting levels broblast growth factor 4 (FGF-4, Research Diagnostics, Inc.). After this incubation, cells were tested in the pres-of 18S ribosomal RNA. Normalized mRNA levels are expressed as a percentage of the mean starting levels of ence of these compounds as described. 
Hepatic Functionality of HFLCs In Vitro Biochemical Assays
Cells were tested for hepatic function and expression Ammonia concentration was determined by an enzypatterns at different time points during culturing and matic kinetic colorimetric assay using glutamate dehycompared to primary mature human hepatocytes under drogenase and NADPH, performed in a P800 Roche Dithe same culture conditions. Primary HFLCs, tested 2 agnostics analyzer. Urea concentration was determined days after isolation, produced similar amounts of albuusing a blood urea nitrogen test according to the instrucmin compared to primary mature human hepatocytes tions of the manufacturer (Sigma Chemical Co). Total (Table 2 ). Urea production rate of primary HFLCs was protein/well was quantified by spectrometry using Coo-4.4-fold lower compared to primary mature human hemassie blue (Bio-Rad). Albumin concentration was depatocytes (p < 0.05) ( Table 2 ). In HFLCs both these termined by enzyme linked immunosorbent assay using functions rapidly decreased after serial passaging. After cross-absorbed goat-anti-human albumin antibodies (Beeight PDs, completed after four passages, urea and albuthyl).
min production rate were decreased 11-and 480-fold, respectively (p < 0.05). Primary mature human hepato-Statistics cytes showed an ammonia elimination rate of 95.2 ± Results are reported as mean ± SD of at least three 60.7 nmol h −1 mg protein −1 . No ammonia elimination independent experiments. Student's t-test was performed was detected for primary HFLCs. to compare outcomes. Results were considered to be sig-To determine whether serial passaging also reduced nificant if p < 0.05. Messenger RNA levels are reported mRNA levels of hepatic genes, we performed RT-PCR as the mean of duplicate experiments; no statistical analanalyses ( Table 2 ). The mRNA levels of genes associysis was performed on these results. ated with hepatic maturation (i.e., albumin, transferrin, AAT, HNF1α, and HNF4) in primary HFLCs were be-RESULTS tween 29% and 196% of mature in vivo levels. After
Morphology of HFLCs In Vitro
eight PDs the mRNA levels of albumin, transferrin, and AAT were reduced to less than 1% of the mature in vivo HFLCs were isolated from fetal livers of 14-18 weeks gestation and taken into culture. We chose to test levels, whereas HNF1α and HNF4 mRNA levels were reduced 7.4-and 3.8-fold to 24% and 51%, respectively. HFLCs of 16 weeks gestational age, because these cells still exhibit a high proliferation capacity and a relatively Cyp3A4 mRNA levels were more than 500-fold lower in primary HFLCs when compared to mature in vivo long life span. The HFLCs performed 57.6 ± 10.2 PDs in culture with a T PD of about 2 days before entering a levels and decreased 3.7-fold after 8 PDs. Genes associated with immature hepatocytes (i.e., GSTπ and AFP) state of terminal growth arrest. HFLCs isolated at 23 weeks gestational age had a reduced life span of 28 PDs showed a similar pattern: primary HFLCs displayed GSTπ and AFP mRNA levels 19-and 68-fold higher and a T PD of 3 days (n = 1).
Primary HFLCs initially consisted mainly of clusters than mature in vivo expression levels, respectively, which reduced to 293% and 21% after eight PDs. of cells with hepatocyte morphology (Fig. 1a ), but the percentage of cells with fibroblast-like morphology rap-mRNA of Cyp3A7, the predominant fetal cytochrome P450 isoform (27) , was only detectable in one of the idly increased in the first week and the hepatocyte-like cell clusters became surrounded by cells with a fibro-two mature liver samples and Cyp3A7 mRNA levels of primary HFLCs were 5.8-fold higher than in this mature blast-like morphology (Fig. 1c ). The addition of HGF and/or EGF did not affect cell growth rate nor did it liver sample. Again, mRNA levels decreased, almost 30fold after 8 PDs. Thus, the mRNA levels of diverse he-inhibit the overgrowth by fibroblast like cells (data not shown). Although not all cells in primary cultures were patic genes decreased after serial passaging. PCNA positive, cells of all morphologies stained posi-Morphology and Functionality of Clonal Derivatives tive for PCNA in cultures of both 2 and 6 days ( Fig.  1b, d ) and were therefore actively dividing. Passaging
To investigate the phenotypic instability of the HFLC cultures, clonal derivatives were acquired by limiting di-of primary HFLCs was associated with rapid loss of the dominant hepatocyte morphology. However, early pas-lution. Clones with an epithelial-like morphology were selected for further investigation, whereas clones with a sages still showed a variety of morphologies, ranging from cells with a cubic, epithelial-like appearance fibroblast-like morphology were excluded. A selection of representative clones is presented in Figure 2b -e. The (marked with C in Fig. 2a ), to stretched, fibroblast-like cells (marked with S in Fig. 2a ). When subculturing was morphology of the selected clones was stable until the cells reached terminal growth arrest. Eight clonal deriva-HFLC PD8 cultures. Two clones, cBAL08 and cBAL29, produced more urea than the HFLC PD8 cultures (p < tives were studied in detail for their growth characteristics. As shown in Figure 3 , all clones displayed a longer 0.05) and cBAL29 produced more albumin (p < 0.05). In cBAL08 and cBAL29, urea production rates were sta-T PD and a reduced life span compared to the original HFLC cultures, except for cBAL08, which reached a ble with increasing PD number (Fig. 4) . Urea production of cBAL08 and cBAL29 was between 4% and 6% of maximal number of PDs of 61.
We performed hepatic function tests in three indepen-the mature primary hepatocytes and albumin production of cBAL29 was 1.3%. So, functionality of the clonal dent experiments on the six clonal derivatives that could undergo at least 30 PDs. No statistical analysis was per-derivatives was still insufficient. At the level of gene expression, no clear preservation formed on the results of cBAL09 and cBAL24, because these cultures could not be expanded in an adequate of function was observed in clonal derivatives, even though differences are observed between clonal deriva-amount for three replicate experiments. Table 2 shows the urea and albumin-producing capacity of the six tives (Table 2) . For example, cBAL20 was the only cell line in which Cyp3A7 was detected. clones tested after at least 30 PDs. The clones differed in their functionality. Functionality seemed to be pre-To determine if the clonal derivatives exhibited a cholangiocyte phenotype, the mRNA levels of two cho-served in some clonal derivatives when compared to the langiocyte markers, CK7 and CK19, were determined. formed at least 20 PDs (Table 3) . Urea synthesis increased 1.8-fold by 10 mM nicotinamid in cBAL29 and The levels of these markers in cBAL08, cBAL09, cBAL21, and cBAL29 were comparable to mature liver 2.2-fold by 5 mM sodiumbutyrate in cBAL08 and cBAL29 (p < 0.05); however, no ammonia elimination in vivo and at least nine times lower than in the cholangiocyte cell lines Mz-ChA-1 and Sk-ChA-1. Only the was detected. In cBAL08 10 ng/ml FGF-4 lowered urea synthesis twofold (p < 0.05). Other compounds showed CK7 mRNA level of cBAL20 was comparable to that of the cholangiocytes. no significant induction of function. The clonal derivatives seemed to be more responsive to differentiation Differentiation Experiments stimuli than the HFLC cultures; however, this was not statistically significant. No significant effects were de-To enhance hepatic functionality, cells were incubated with agents that are reported to induce or preserve tected on albumin synthesis. At the level of gene transcription, 10 mM nicoti-the hepatic phenotype in vitro of fetal liver cells, mature hepatocytes, bone marrow cells, or embryonic stem namid increased albumin, transferrin, and AAT mRNA levels of cBAL08 almost twofold without affecting cells. For these studies we used HFLCs after 12 PDs and the two clonal derivatives with the highest hepatic GSTπ and AFP mRNA levels. Treatment of cBAL08 with 1 µM retinoic acid upregulated transferrin mRNA function (i.e., cBAL08 and cBAL29) after they per- levels more than 11 times, while it almost abolished relation between Cyp3A4 and Cyp3A7 and its shift during liver development is a well-known phenomenon AAT mRNA levels. This effect was confirmed in cBAL29 in which retinoic acid caused an 8.7-fold in- (27) . Primary HFLCs can be easily expanded in vitro. In crease of transferrin mRNA level (data not shown).
this study, HFLCs were expanded in culture medium DISCUSSION based on DMEM enriched with 10% HI-FBS to support proliferation, as described previously (13, 31) . Culture For a reliable evaluation of an alternative cell source for in vitro hepatic function, comparison with mature medium was enriched with a mixture of insulin, transferrin, and selenium as adapted from Lazaro et al. (11) and human hepatocytes under the same conditions is of vital importance. To our knowledge, this comparison has dexamethasone was added to maintain in vitro hepatic differentiation (7, 9, 20) . However, these supplements never been reported for HFLCs. We show that the functionality of primary HFLC cultures is comparable to that could not prevent the progressive loss of hepatic morphology and functionality during eight PDs. This loss of of primary mature human hepatocytes for albumin production and the mRNA levels of albumin, transferrin, function is consistent with the loss of function in progenitor liver epithelial cells during eight passages re-AAT, HNF1α, and HNF4. More complex functions, like expression of cytochrome p450 and urea production ported previously (13). The addition of HGF and/or EGF did not affect cell growth of the epithelial cells from ammonia, were lower in HFLCs when compared to mature hepatocytes.
nor the fibroblast-like cells, possibly because of the high serum percentage of the medium, which contains many Ureagenesis was 4.4-fold lower in HFLCs compared to mature human hepatocytes and ammonia elimination growth factors. Changes in morphology and functionality of the was not detected in HFLCs. So, HFLCs isolated at 16 weeks gestation do not exhibit a functional urea cycle in HFLC culture result, at least partly, from the heterogeneity of the isolated cell population. Part of the cells vitro. This is probably a reflection of the in vivo functionality of fetal liver. In subjects with inborn urea cycle with hepatocyte morphology present in the primary cultures are PCNA positive, thus proliferating, but are rap-deficiencies, the ammonia accumulation starts shortly after birth (12). This indicates that the ammonia removal idly outnumbered by cells with fibroblast-like morphology. After passaging HFLCs, the dominance of hepatocyte in utero can take place through the placenta and only after birth does the liver become the site of action. morphology is lost. This might be a result of the trypsin treatment, which is known to damage cell-cell connec-Cyp3A4 mRNA levels are more than 500-fold lower and Cyp3A7 mRNA levels are 5.8-fold higher in primary tions and cell-extracellular matrix connections (16). Extracellular matrix provides hepatocytes with signals im-HFLCs when compared to mature liver. This reciprocal portant for the maintenance of differentiation status (1). overgrown by fibroblast-like cells. When the cells with an epithelial morphology were clonally expanded, their Another explanation for the loss of the hepatocyte morphology can be that the cells undergo EMT, as described population was stable until terminal growth arrest occurred, but they grew slower than the HFLCs and the for fetal rat hepatocytes (30) . However, the high levels of HNF1α and HNF4 mRNA in passaged HFLCs and life span of most of the clones was shorter. Thus, selecting the optimal cell type can partly stabilize the pheno-the clonal derivatives contradict the observed low HNF1α and HNF4 mRNA levels in EMT (30) . Finally, type and prevent overgrowth by fibroblast-like cells. Although heterogeneity of the HFLC population is the epithelial cells in the HFLC cultures may have been involved in the functional and morphological instability of the cultures, dedifferentiation of the cells, due to applied culture conditions, cannot be excluded. Optimizing culture conditions may inhibit or even reverse this process. Therefore, we selected compounds that are reported to induce or preserve the in vitro hepatic phenotype of fetal liver cells, mature hepatocytes, bone marrow cells, or embryonic stem cells (3,14,23,25) and tested their effects on cBAL08, cBAL29, and HFLCs after 12 PDs. Induction of urea production rate was possible in cell lines cBAL29 and cBAL08, but was limited with a maximum of a twofold induction by addition of butyrate. No induction of both urea and albumin production was observed by the addition of DMSO, oncostatin M, retinoic acid, HGF, and FGF-4. None of the studies that described the differentiating effects of compounds we selected used HFLCs, which may explain the discrepancies found. Furthermore, the continued proliferation under the applied culture conditions may not support drastic hepatic differentiation in vitro as in vitro proliferation and differentiation seem to be mutually exclusive.
Our limiting dilution assay did not select for hepatic functionality, but only for morphology. This may also explain the limited functionality of the clonal derivatives. However, the low mRNA levels of cholangiocyte markers in most of the cell lines that were selected, combined with HNF1α and HNF4 levels that are comparable to mature human hepatocytes indicate that the clonal de- 
langiocytes.
Many studies aim at finding cellular markers that can select the most functional cell types from primary HFLC 1.3 ± 1.6 1.9 ± 1.3 1.0 ± 0.6 1.4 ± 0.6 2.0 ± 1.2 0.4 ± 0.3 0.7 1.2 0.7 0.6 0.4 10 mM NA 0.6 ± 0.5 0.9 ± 0.5 1.0 ± 0.3 0.7 ± 0.3 1.8 ± 0.4* 0.7 ± 0.3 1.9 1.9 1.8 0.9 0.8 10 ng/ml OSM 1.7 ± 1.0 1.3 ± 1.2 0.9 ± 0.2 0.8 ± 0.7 1.5 ± 0.5 0.7 ± 0.2 0.6 0.9 0.4 0.6 0.2 5 mM Butyrate 1.5 ± 1.5 1.1 ± 1.2 1.1 ± 0.9 2.2 ± 0.3* 2.2 ± 0.5* 1.7 ± 0.5 1.1 0.2 0.9 0.7 0.2 1 µM RA 2.0 ± 2.4 1.1 ± 0.3 0.9 ± 0.6 1.5 ± 0.6 2.1 ± 1.4 0.8 ± 0.3 1.2 11.3 0.0 0.5 0.4 10 ng/ml HGF 0.6 ± 0.8 1.6 ± 1.0 1.0 ± 0.1 0.7 ± 0.3 1.1 ± 0.4 0.7 ± 0.6 1.1 1.4 1.3 1.0 1.0 10 ng/ml FGF-4 1.3 ± 1.4 1.3 ± 1.0 0.6 ± 0.3 0.5 ± 0.2* 1.4 ± 0.4 0.4 ± 0.2* 0.6 1.2 1.2 1.0 0.7 *p < 0.05 compared to basic medium.
